ViviCells Competitors

VCII Stock  USD 0.0001  0.00  0.000003%   
Analyzing ViviCells International competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of ViviCells International to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out ViviCells International Correlation with its peers.
For more detail on how to invest in ViviCells Stock please use our How to Invest in ViviCells International guide.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of ViviCells International competition on your existing holdings.
The current Return On Tangible Assets is estimated to decrease to -0.0077. The current Return On Capital Employed is estimated to decrease to -0.0069. The ViviCells International's current Debt To Assets is estimated to increase to 0.19, while Total Assets are projected to decrease to under 4.9 M.
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000840.00
Details
Naive
Forecast
LowNextHigh
0.00010.00010.0001
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details

ViviCells International Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between ViviCells International and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of ViviCells and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of ViviCells International does not affect the price movement of the other competitor.

High positive correlations

CMNRCGEI
ZHYLFCGEI
NCENCGEI
FEWPCGEI
ARSCCGEI
ZHYLFCMNR
  

High negative correlations

ARSCNKWFF
FEWPNKWFF
ARSCARAO
FEWPARAO
NKWFFARAO
NKWFFNCEN

Risk-Adjusted Indicators

There is a big difference between ViviCells Stock performing well and ViviCells International Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ViviCells International's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CGEI  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
BLSP  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
CMNR  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ZHYLF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
NCEN  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ARAO  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
NKWFF  2.97 (1.64) 0.00 (0.88) 0.00 
 0.00 
 99.43 
FEWP  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ARSC  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

Cross Equities Net Income Analysis

Compare ViviCells International and related stocks such as CGE Energy, Blue Sphere Corp, and Commerce Energy Group Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity
2010201120122013201420152016201720182019202020212022202320242025
BLSP(7.4 M)(7.4 M)(7.4 M)(7.4 M)(7.4 M)(7.4 M)(1.8 M)(3.9 M)(10.4 M)(10.4 M)(10.4 M)(10.4 M)(10.4 M)(10.4 M)(9.4 M)(9.9 M)
FEWP(195.6 K)(534 K)(534 K)(534 K)(534 K)(534 K)(534 K)(534 K)(534 K)(534 K)(534 K)(534 K)(534 K)(534 K)(480.6 K)(456.5 K)
ARSC(2.5 M)(611.8 K)(495.9 K)(599.6 K)(8.1 K)(8.1 K)(8.1 K)(8.1 K)(8.1 K)(8.1 K)(8.1 K)(8.1 K)(8.1 K)(8.1 K)(9.3 K)(9.7 K)

ViviCells International and related stocks such as CGE Energy, Blue Sphere Corp, and Commerce Energy Group Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in ViviCells International financial statement analysis. It represents the amount of money remaining after all of ViviCells International operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

ViviCells International Competitive Analysis

The better you understand ViviCells International competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, ViviCells International's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across ViviCells International's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
VCII CGEI BLSP CMNR ZHYLF NCEN NKWFF FEWP ARSC
 0.000003 
 0.0001 
ViviCells
 0.00 
 0.0001 
CGE
 0.00 
 0.000001 
Blue
 0.00 
 0.0001 
Commerce
 0.00 
 0.0002 
Zhaoheng
 0.00 
 0.0001 
Nacel
 0.00 
 0.0002 
Oceanic
 0.000003 
 0.0001 
Far
 0.000003 
 0.0001 
American
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Current Asset
Retained Earnings
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Z Score
Return On Asset
Book Value Per Share
Number Of Shares Shorted
Current Liabilities
Total Asset
Debt To Equity
Target Price
Short Ratio
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Daily Balance Of Power
Day Typical Price
Rate Of Daily Change
Day Median Price
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Standard Deviation
Kurtosis
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Information Ratio

ViviCells International Competition Performance Charts

Five steps to successful analysis of ViviCells International Competition

ViviCells International's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by ViviCells International in relation to its competition. ViviCells International's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of ViviCells International in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact ViviCells International's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to ViviCells International, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your ViviCells International position

In addition to having ViviCells International in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Israel Wall Street Thematic Idea Now

Israel Wall Street
Israel Wall Street Theme
Cross-sector collection of best publicly traded Israel entities that are expected to continue growing. The Israel Wall Street theme has 31 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Israel Wall Street Theme or any other thematic opportunities.
View All  Next Launch
When determining whether ViviCells International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ViviCells International's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vivicells International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vivicells International Stock:
Check out ViviCells International Correlation with its peers.
For more detail on how to invest in ViviCells Stock please use our How to Invest in ViviCells International guide.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Independent Power and Renewable Electricity Producers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ViviCells International. If investors know ViviCells will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ViviCells International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Revenue Growth
(0.27)
The market value of ViviCells International is measured differently than its book value, which is the value of ViviCells that is recorded on the company's balance sheet. Investors also form their own opinion of ViviCells International's value that differs from its market value or its book value, called intrinsic value, which is ViviCells International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ViviCells International's market value can be influenced by many factors that don't directly affect ViviCells International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ViviCells International's value and its price as these two are different measures arrived at by different means. Investors typically determine if ViviCells International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ViviCells International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.